Related Experiment Videos
[Antithrombotic therapy and dental surgery with bleeding]
R H B Allard1, J A Baart, P C Huijgens
1Uit de afdeling Mondziekten en Kaakchirurgie, VU medisch centrum/ ACTA, Amsterdam. rhb.allard@vumc.nl
Nederlands Tijdschrift Voor Tandheelkunde
|January 14, 2005
Summary
For most dental procedures, continuing aspirin or clopidogrel is safe and avoids increased risks of blood clots. Consult a specialist if unsure or using other antithrombotic therapies.
Area of Science:
- Cardiology
- Oral Surgery
- Pharmacology
Background:
- Antithrombotic therapy is crucial for preventing thrombo-embolic events.
- Stopping or reducing antithrombotic medication increases bleeding risk but may be necessary for surgery.
- Balancing these risks is essential for patient safety.
Purpose of the Study:
- To evaluate the necessity of discontinuing antithrombotic therapy for dental surgery.
- To provide guidance on managing antithrombotic medications in the context of dental procedures.
- To discuss the treatment of postoperative hemorrhage and associated medico-legal aspects.
Main Methods:
- Literature review of studies on antithrombotic therapy and dental surgery.
- Analysis of risks and benefits of continuing or stopping aspirin and clopidogrel.
- Review of guidelines for managing postoperative hemorrhage.
Main Results:
- In general, continuing aspirin or clopidogrel is not necessary to stop for routine dental surgery.
- The risk of thrombo-embolic complications must be weighed against the risk of bleeding.
- Consultation with a medical specialist is advised for uncertain cases or alternative antithrombotic therapies.
Conclusions:
- Routine dental surgery can often be performed without interrupting aspirin or clopidogrel therapy.
- Management decisions should be individualized based on patient risk factors and procedure type.
- Clear protocols for managing hemorrhage and understanding medico-legal implications are important.